RecruitingNot ApplicableNCT07006428

Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens

Visual Performance Differences Between Clareon PanOptix and a Comparable Multifocal Intraocular Lens


Sponsor

Argus Research Center, Inc.

Enrollment

290 participants

Start Date

May 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective pilot phase and a prospective, randomized comparison phase.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Clareon PanOptix or PanOptix Toric IOLs and a medical device called Comparable multifocal IOL for people with age related cataracts. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEClareon PanOptix or PanOptix Toric IOLs

Bilateral implantation of the Clareon PanOptix or PanOptix Toric IOLs.

DEVICEComparable multifocal IOL

Bilateral implantation of a comparable multifocal IOL


Locations(3)

Wolstan & Goldberg Eye Associates

Torrance, California, United States

Tyson Eye

Cape Coral, Florida, United States

North Georgia Eye Associates

Gainesville, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07006428


Related Trials